Martinez Suky, Jones Jermaine D, Brandt Laura, Hien Denise, Campbell Aimee N C, Batchelder Sarai, Comer Sandra D
Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.
Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.
Drug Alcohol Depend. 2021 Apr 1;221:108632. doi: 10.1016/j.drugalcdep.2021.108632. Epub 2021 Feb 16.
Resilience is defined as the capacity for an individual to maintain normal functioning and resist the development of psychiatric disorders in response to stress and trauma. Although previous investigators have acknowledged the important role of resilience in those with substance use disorders, this is the first study to investigate the reliability, validity, and factor structure of the Connor-Davidson Resilience Scale (CD-RISC-25) in a sample of individuals with opioid use disorder (OUD). Additionally, we explored the relationship between trait resilience and the severity of drug-related problems.
Four hundred and three participants (22 % female) with OUD completed the CD-RISC-25, Beck Depression Inventory (BDI-II), and the self-report Addiction Severity Index (ASI). Confirmatory factor analysis (CFA) tested the originally proposed 5-factor solution of the CD-RISC-25.
CFA results indicated that a 5-factor model of the CD-RISC-25 performed somewhat better than the 1-factor solution. Pearson correlation revealed a negative association between CD-RISC-25 (M = 75.82, SD = 15.78) and ASI drug-use composite score (M = .25, SD=-0.16), r=-0.148, p<.01, and between CD-RISC-25 and BDI-II (M = 11.33, SD = 10.58), r=-.237, p<.001.
Albeit providing only limited support for the original 5-factor structure, our results indicate that the scale may be useful for screening individuals with OUD who have a vulnerability to stress. Consistent with prior studies, higher resilience was associated with lower depression symptoms and addiction severity, further demonstrating the CD-RISC-25 ability to predict psychiatric stability. To inform the development of more targeted interventions, future studies should examine resilience longitudinally, in addition to exploring more comprehensive approaches to measuring resilience.
心理韧性被定义为个体在面对压力和创伤时维持正常功能并抵御精神障碍发展的能力。尽管先前的研究者已经认识到心理韧性在物质使用障碍患者中的重要作用,但这是第一项在阿片类物质使用障碍(OUD)个体样本中调查Connor-Davidson心理韧性量表(CD-RISC-25)的信度、效度和因子结构的研究。此外,我们还探讨了特质心理韧性与药物相关问题严重程度之间的关系。
403名患有OUD的参与者(22%为女性)完成了CD-RISC-25、贝克抑郁量表(BDI-II)和自我报告成瘾严重程度指数(ASI)。验证性因子分析(CFA)检验了CD-RISC-25最初提出的五因子模型。
CFA结果表明,CD-RISC-25的五因子模型比单因子模型表现稍好。Pearson相关性分析显示,CD-RISC-25(M = 75.82,SD = 15.78)与ASI药物使用综合评分(M = 0.25,SD = -0.16)之间呈负相关,r = -0.148,p <.01;CD-RISC-25与BDI-II(M = 11.33,SD = 10.58)之间也呈负相关,r = -0.237,p <.001。
尽管我们的结果仅为CD-RISC-25最初的五因子结构提供了有限支持,但表明该量表可能有助于筛查易受压力影响的OUD个体。与先前的研究一致,较高的心理韧性与较低的抑郁症状和成瘾严重程度相关,进一步证明了CD-RISC-25预测精神稳定性的能力。为了为更有针对性的干预措施的开发提供信息,未来的研究除了探索更全面的心理韧性测量方法外,还应纵向研究心理韧性。